(-)-formoterol, a selective beta 2-adrenoreceptor agonist

Area of Science:

• Crystallography
• Medicinal Chemistry
• Organic Chemistry

Background:

• (-)-Formoterol is a key bronchodilator used in asthma and COPD treatment.
• Understanding the precise stereochemical configuration of pharmaceuticals is crucial for efficacy and safety.
• Previous studies proposed the configuration of (-)-formoterol based on chemical correlations.

Purpose of the Study:

• To determine the absolute crystal structure of (-)-formoterol.
• To elucidate the compound's stereochemical configuration relative to (+)-tartrate.
• To validate proposed configurations through direct structural analysis.

Main Methods:

• Single-crystal X-ray diffraction analysis of (-)-formoterol (+)-tartrate salt.
• Analysis of crystallographic data to determine atomic positions and stereochemistry.
• Comparison of the determined structure with configurations derived from chemical methods.

Main Results:

• The crystal structure of (-)-formoterol was successfully determined.
• The absolute configuration of (-)-formoterol was unequivocally established.
• The determined configuration is in complete agreement with that proposed by prior chemical correlation studies.

Conclusions:

• The crystal structure determination provides definitive evidence for the configuration of (-)-formoterol.
• This structural elucidation validates the reliability of chemical correlation methods in stereochemical assignments.
• The findings contribute to a deeper understanding of formoterol's molecular properties and its interactions.